Los puntos clave no están disponibles para este artículo en este momento.
Research data suggest an association between antipsychotic‐induced hyperprolactinemia and higher risk of breast cancer (Rahman et al., 2022; also, see “Breast cancer risk with antipsychotic use linked to prolactin levels;” https://doi.org/10.1002/pu.30853 ). This is likely secondary to the anti‐dopaminergic properties of antipsychotics, especially those of first‐generation agents.
Y. W. Francis Lam (Wed,) studied this question.